Eli Lilly faces challenges in the GLP-1 market, with Novo Nordisk gaining a timing advantage in both injectable and oral drug approvals.
2 minute read
Evercore ISI analysts cautioned investors, writing Thursday that “with regards to current headlines, we see no meaningful revenue opportunity.”
2 minute read
CVS Health’s Aetna was the third-largest provider of Medicare Advantage plans in 2025, behind UnitedHealth Group and Humana.
3 minute read
The insurance company has plans to get smaller in Medicare Advantage. Goldman Sachs likes the idea.
2 minute read
The company modestly raised its forecast for 2026 profits amid a shift in its drug pricing and CEO transition.
2 minute read
The stock has slumped this year, seesawing on news of how much the government plans to pay insurers that operate Medicare Advantage health plans for seniors.
3 minute read
Regeneron, in a press release, said it would get tariff relief for three years under terms with the U.S. Department of Commerce.
2 minute read
The health insurer cites improvements in Medicare Advantage and says it’s making $1.5 billion in AI investments.
Long Read
The health secretary told lawmakers the department’s proposed budget focuses on prevention because it has better outcomes than treatment.
2 minute read
About 35 million beneficiaries are in Medicare Advantage plans this year, according to the health research group KFF.
3 minute read
The agreement would cover the company’s Caremark pharmacy benefit manager unit, which has denied wrongdoing.
1 minute read
One feature will allow Fitbit users to share their medical records with the app’s AI-powered health coach.
2 minute read
Aetna paid a $117.7 million settlement over allegations it submitted inaccurate diagnosis code to inflate Medicare payments.
1 minute read
Vice President JD Vance shocked Europeans in at last year’s conference, saying the biggest threat to the continent isn’t China or Russia, but a turn away from “democratic values.”
2 minute read
Midlevel healthcare jobs more than doubled between 2010 and 2022.
2 minute read
The vaccine maker says the Food and Drug Administration has refused to review its application to sell a new seasonal flu vaccine.
2 minute read
Humana shares are down more than 30% since the federal government announced plans last month to keep Medicare Advantage rates nearly flat in 2027.
2 minute read
UnitedHealth Group‘s latest selloff is one more painful moment in a run of tough times for the stock.
Long Read
The CEOs of large health insurers testified Thursday on Capitol Hill amid a rising focus on healthcare costs.
2 minute read
of 3 pages